Topotecan inhibits VEGF‐ and bFGF‐induced vascular endothelial cell migration via downregulation of the PI3K‐Akt signaling pathway

Ayako Nakashio(GlaxoSmithKline (Japan)), Takashi Tsuruo(Chemotherapy Foundation)
International Journal of Cancer
December 18, 2001
Cited by 93


Related Papers